Summary
Overview
Work History
Education
Timeline
Generic

Pete Fresca

Lexington,KY

Summary

Highly Accomplished Leader with extensive knowledge of Buy and Bill, market access, reimbursement, billing and coding and targeted patient services. Entrepreneurial experience with exceptional ability to build and develop diverse teams committed to excellence. Broad cross-functional and collaborative experience with focus on operational excellence and leadership with solution-oriented, patient centered approach.

Overview

20
20
years of professional experience

Work History

Field Director Patient Access

Takeda Rare Disease
12.2019 - Current
  • Experience building, leading, and developing successful Patient Access teams across multiple therapeutic areas, including Lysosomal Storage Disorder (LSD), Endocrinology, Primary Immunodeficiency (PI) and Neuromuscular
  • Co-Lead team of 15 Patient Access Managers navigating complex access, reimbursement, and payer challenges in Rare Specialty Pharmaceutical and Buy and Build markets
  • Led expansion of field-based access team dedicated to access support for Primary Immunodeficiency and Chronic Inflammatory Demyelinating Polyneuropathy
  • Patient Access launch lead for cross-functional workstream, transitioning from internal patient services hub to external hub services
  • Assisting in continued development
  • Contributed to development of integrated digital evolution strategy for Patient Services
  • Developed Ways of Working document for clear and precise understanding of processes and promote open compliant communication within Takeda
  • Partner with Patient Services Marketing in creating all Takeda Patient Support materials for medical professionals and patients
  • Created and led the implementation of newly formed PAM Mentorship Program
  • Strong ability to develop relationships to inspire teams to maximize productivity and outcomes
  • One Takeda Award 2022.

Associate Director of Patient Access

Takeda
01.2018 - 12.2019
  • Provided logistical access and reimbursement education, patient assistance and support for rare diseases (Hunter Syndrome,Gaucher disease and Hyperparathyroidism) Collaborate directly with internal and external partners providing expertise and education on federal, commerical, Medicare/Medicaid coverage, and policy
  • Resolved access issues by collaborating with internal and external groups, including patients, healthcare providers, payers, specialty pharmacies, and advocacy organizations
  • Participated in regular cross-functional team meetings to coordinate patient services activities and field activities; cross functional team includes case managers, regional disease education managers, and field sales leadership.

Regional Business Manager - Natpara

Takeda
06.2016 - 01.2018
  • 2017 Final Rank 1/79 for Natpara, Achieved Presidents Club
  • 2016 ranked 10/58 nationally for Natpara 2nd half of the year
  • Selected by peers as MVP of region for 2017, exemplifying Shire Leadership Behaviors – Be Accountable, Be Positive, Be Results Driven, Be an Excellent Manager of Self & Others.

Executive Sales Representative

Smith & Nephew Biotherapeutics
03.2012 - 06.2016
  • 015 ranked 3/225 with emphasis brands (Santyl Regranex and Oasis)
  • 2014 ranked 18/248 with emphasis brands (Santyl Regranex and Oasis)
  • Appointed to National Managed Markets Development Program in 2015
  • Selected as one of 10 Regranex Training Specialists focused on training field to assist medical professionals with access, coverage, reimbursement, and financial assistance
  • Appointed to RFIT (Regranex Field Intelligence Team) cross functional team to coordinate patient service activities and field activities
  • Interim Manager for Ohio Valley District from June 2014 to January 2015
  • Co-Developed Santyl Specialty Pharmacy Strategy and led the national implementation.

Senior Metabolism Institutional

Sanofi-Aventis Pharmaceuticals
04.2004 - 02.2012
  • 2011 Ranked 2/48 in region and 16/160 nationally
  • 2010 Ranked 1/48 in region and 13/160 nationally
  • 2009 Ranked 6/56 in nation obtaining a Sales Champion Award
  • 2008 attainment of 107% on total portfolio with year-end ranking of 11/60
  • 2007 attainment of 101% on total portfolio with year-end ranking of 19/60
  • Selected by training department to develop and implement training materials for Lantus/Apridra Retrain 2008
  • Extensive experience with P&T committees, Materials Management, and C Suite due to the launch of Apidra and Lantus SoloStar.

  • Chosen as lead for pilot program of Next Generation Sales Task Force – Partnering with cross functional team to increase patient access to products.

Education

Bachelor of Arts - Marketing/Management

University of Kentucky
Lexington, KY
12.1994

Timeline

Field Director Patient Access

Takeda Rare Disease
12.2019 - Current

Associate Director of Patient Access

Takeda
01.2018 - 12.2019

Regional Business Manager - Natpara

Takeda
06.2016 - 01.2018

Executive Sales Representative

Smith & Nephew Biotherapeutics
03.2012 - 06.2016

Senior Metabolism Institutional

Sanofi-Aventis Pharmaceuticals
04.2004 - 02.2012

Bachelor of Arts - Marketing/Management

University of Kentucky
Pete Fresca